Clinical Trials Directory

Trials / Completed

CompletedNCT00340054

Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields

Assessment of Occupational EMF Exposure - Validation of Interview Procedures Used in Brain Tumor Study

Status
Completed
Phase
Study type
Observational
Enrollment
108 (estimated)
Sponsor
National Institutes of Health Clinical Center (CC) · NIH
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Electric and magnetic fields may increase the risk of cancer. Developing interview questions that accurately estimate a person's exposure to electric and magnetic fields may help doctors learn about the long-term effects of workplace exposure. PURPOSE: This clinical trial is developing interview questions that can be used in estimating workplace exposure to electric and magnetic fields.

Detailed description

OBJECTIVES: * Validate an interview-based electric and magnetic field exposure (EMF) assessment algorithm against measurements of the time-weighted average magnetic field magnitude used in previous epidemiologic studies. * Calibrate the parameters in the algorithm in order to improve the exposure estimates. * Correlate EMF exposure estimates from the algorithm with biologically based metrics measured by new instrumentation. OUTLINE: Participants respond to questions during a 5- to 15-minute telephone interview concerning workplace exposure to electric and magnetic (EMF) fields. Data is collected during the interview using an exposure assessment algorithm designed to estimate EMF workplace exposure based on participants' responses. The interview-based estimates are then validated against actual field measurements of magnetic field exposure captured by Emdex multiwave monitors located at participating sites.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaire administration
PROCEDUREstudy of high risk factors

Timeline

Start date
2005-10-01
Completion
2007-03-01
First posted
2006-06-21
Last updated
2012-03-08

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00340054. Inclusion in this directory is not an endorsement.